Examining orexinergic modulation of the paraventricular nucleus of the thalamus as a novel therapeutic for PTSD and comorbid psychosis
检查丘脑室旁核的食欲素调节作为 PTSD 和共病精神病的新型治疗方法
基本信息
- 批准号:10579193
- 负责人:
- 金额:$ 1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-01 至 2023-05-26
- 项目状态:已结题
- 来源:
- 关键词:AdultAntipsychotic AgentsAwardBehaviorBehavioralBindingBrainBrain regionCellsCognitive deficitsCommunicationComplexControl AnimalCoupledDataDelusionsDiagnosisDiseaseDopamineDoseElectrodesElectrophysiology (science)Enterobacteria phage P1 Cre recombinaseEventFellowshipFiberFunctional disorderG alpha q ProteinGeneticGoalsHallucinationsHypothalamic structureIncidenceIndividualIontophoresisLabelLateralLigandsMeasuresMedialMediatingMental disordersNeuronsNeuropeptidesNucleus AccumbensOpticsPathologicPathologyPathway interactionsPatientsPatternPeptidesPhotometryPopulationPost-Traumatic Stress DisordersPostdoctoral FellowPrefrontal CortexProductivityPsychosesRattusResearchResearch PersonnelRodent ModelRoleScienceSignal TransductionSiteSprague-Dawley RatsStressStressful EventStructure of paraventricular nucleus of thalamusSymptomsSynapsesSystemTechniquesTestingTherapeuticTherapeutic EffectTrainingUnited StatesVentral Tegmental AreaVirusWorkantagonistcareercareer developmentcomorbiditydesigner receptors exclusively activated by designer drugsdopamine systemdopaminergic neuronexperienceexperimental studyextracellularhypocretinin vivoneuronal circuitryneurophysiologynew therapeutic targetnovel therapeuticsorexin 1 receptororexin Aorexin Borexin B receptorpharmacologicprepulse inhibitionreceptorreduce symptomsskillssuccesssymposiumtraumatic event
项目摘要
Project Abstract
Post-traumatic stress disorder (PTSD) is a prevalent condition that afflicts approximately 8% of the United States
population. In addition to core symptoms of the disorder, up to 64% of individuals diagnosed with PTSD
experience symptoms of psychosis, such as hallucinations and delusions. Although the incidence of this
comorbidity is high, treatment for PTSD and comorbid psychosis remains inadequate. However, recent work has
demonstrated the antipsychotic potential of orexin receptor antagonists in a rodent model used to study PTSD.
Selective and nonselective orexin receptor antagonists, when administered systemically, can alleviate
psychosis-like neurophysiological and behavioral deficits in a rodent model used to study PTSD. Orexin
receptors are expressed throughout the brain but the paraventricular nucleus of the thalamus (PVT) receives the
highest concentration of orexin fibers, suggesting orexin receptor antagonists can significantly inhibit activity of
the PVT. It has been shown that chemogenetic activation of projections from the PVT to the nucleus accumbens
(NAc) increase dopamine neuron activity in the ventral tegmental area, which underlies psychosis-like behavior.
Further, the PVT is a stress-sensitive region and discrete projections from the PVT to the NAc become activated
following stressful events. Taken together, these data suggest that stress increases the activity of PVT NAc
projections and this heightened activity results in an increase in downstream dopamine neuron activity. Orexin
receptors are highly expressed within the PVT; therefore, it is further hypothesized that orexin receptor
antagonists alleviate psychosis-like behavior by inhibiting the activity of PVT NAc projections following stress.
In the current proposal two-day inescapable footshock will be used to induce stress-related pathophysiology in
Sprague Dawley rats. Aim 1 will test the hypothesis that footshock stress-induced increases in the firing rate of
PVT NAc projecting neurons are reversible by selective orexin receptor antagonists. Aim 2 will test the
hypothesis that inhibition of PVT NAc projections will normalize stress-induced increases in dopamine neuron
activity and reverse deficits in prepulse inhibition of startle. The proposed studies will examine the role of
PVT NAc projections in mediating psychosis-like behavior and examine the direct effect of selective orexin
receptor antagonists on PVT NAc projections, following stress. Ultimately this proposal aims to uncover novel
therapeutic targets that will alleviate symptoms of psychosis associated with PTSD.
My long-term goal is to become an independent neuroscientist that studies circuit-level alterations contributing
to psychiatric disorders. The research plan described above will provide me with scientific training in techniques,
such as fiber photometry and chemogenetics, that I will utilize throughout my career to examine and manipulate
neuronal circuits. Further, I will present data gathered from these experiments at local and national conferences
and enhance my science communication skills. This award will provide me with scientific and career development
training that will prepare me for a productive postdoctoral fellowship and success as an independent researcher.
项目摘要
创伤后应激障碍 (PTSD) 是一种普遍存在的疾病,困扰着大约 8% 的美国人口
人口。除了该疾病的核心症状外,高达 64% 的人被诊断患有 PTSD
出现精神病症状,例如幻觉和妄想。虽然这种情况的发生
合并症很高,对创伤后应激障碍(PTSD)和合并症精神病的治疗仍然不足。然而,最近的工作已经
在用于研究 PTSD 的啮齿动物模型中证明了食欲素受体拮抗剂的抗精神病潜力。
选择性和非选择性食欲素受体拮抗剂,当全身给药时,可以缓解
用于研究创伤后应激障碍(PTSD)的啮齿动物模型中存在类似精神病的神经生理和行为缺陷。食欲素
受体在整个大脑中表达,但丘脑室旁核 (PVT) 接收
食欲素纤维浓度最高,表明食欲素受体拮抗剂可以显着抑制食欲素纤维的活性
PVT。研究表明,从 PVT 到伏隔核的投射的化学遗传学激活
(NAc) 增加腹侧被盖区的多巴胺神经元活性,这是精神病样行为的基础。
此外,PVT 是一个应力敏感区域,从 PVT 到 NAc 的离散投影被激活
发生应激事件后。综上所述,这些数据表明压力会增加 PVT NAc 的活性
预测和这种增强的活动导致下游多巴胺神经元活动的增加。食欲素
受体在 PVT 内高度表达;因此,进一步推测食欲素受体
拮抗剂通过抑制压力后 PVT NAc 投射的活动来减轻精神病样行为。
在当前的提案中,将使用两天不可避免的足部电击来诱发与压力相关的病理生理学
斯普拉格道利鼠。目标 1 将检验以下假设:足部冲击应力引起的放电率增加
PVT NAc 投射神经元可通过选择性食欲素受体拮抗剂逆转。目标 2 将测试
假设抑制 PVT NAc 投射将使压力诱导的多巴胺神经元增加正常化
活性和逆转惊吓前脉冲抑制的缺陷。拟议的研究将探讨
PVT NAc 预测在调节精神病样行为中的作用并检查选择性食欲素的直接影响
应激后PVT NAc 预测的受体拮抗剂。最终该提案旨在发现新颖的
治疗目标将减轻与 PTSD 相关的精神病症状。
我的长期目标是成为一名独立的神经科学家,研究回路水平的改变,
到精神疾病。上述研究计划将为我提供科学的技术训练,
例如纤维光度测定法和化学遗传学,我将在我的整个职业生涯中利用它们来检查和操纵
神经元回路。此外,我将在地方和国家会议上展示从这些实验中收集的数据
并提高我的科学沟通能力。该奖项将为我提供科学和职业发展
培训将使我为获得富有成效的博士后奖学金和作为一名独立研究员的成功做好准备。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Increased Presynaptic Dopamine Synthesis Capacity Is Associated With Aberrant Dopamine Neuron Activity in the Methylazoxymethanol Acetate Rodent Model Used to Study Schizophrenia-Related Pathologies.
- DOI:10.1093/schizbullopen/sgac067
- 发表时间:2022-01
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hannah Elam其他文献
Hannah Elam的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
抗精神病药治疗精神分裂症的西方与中国临床研究证据:建立联合数据库及运用网状meta分析方法
- 批准号:
- 批准年份:2021
- 资助金额:100 万元
- 项目类别:
第二代抗精神病药通过CB1R导致心肌细胞焦亡的作用机制及临床意义
- 批准号:82070285
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
基于Circ-Insig2 /miR-421-3p/FOXO3轴调控成骨细胞自噬探讨抗精神病药利培酮导致骨质疏松的作用及机制
- 批准号:
- 批准年份:2020
- 资助金额:33 万元
- 项目类别:
非典型抗精神病药物所致体重增加的遗传易感区域精细定位研究
- 批准号:81901358
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
基于阻断内质网应激-炎症反应治疗抗精神病药所致肥胖的研究
- 批准号:81803515
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Brain Development after Early-Life Antipsychotic Treatment
早期抗精神病治疗后的大脑发育
- 批准号:
10629613 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别:
What the Nose Knows: Hedonic Capacity, Psychosocial Interventions and Outcomes in Schizophrenia
鼻子知道什么:精神分裂症的享乐能力、社会心理干预和结果
- 批准号:
10453080 - 财政年份:2022
- 资助金额:
$ 1万 - 项目类别:
Optimizing Care to Prevent Diabetes and Promote Cardiovascular Health Among Younger Adults with Severe Mental Illness
优化护理以预防患有严重精神疾病的年轻人的糖尿病并促进心血管健康
- 批准号:
10370889 - 财政年份:2022
- 资助金额:
$ 1万 - 项目类别:
Optimizing Care to Prevent Diabetes and Promote Cardiovascular Health Among Younger Adults with Severe Mental Illness
优化护理以预防患有严重精神疾病的年轻人的糖尿病并促进心血管健康
- 批准号:
10584516 - 财政年份:2022
- 资助金额:
$ 1万 - 项目类别:
What the Nose Knows: Hedonic Capacity, Psychosocial Interventions and Outcomes in Schizophrenia
鼻子知道什么:精神分裂症的享乐能力、社会心理干预和结果
- 批准号:
10612488 - 财政年份:2022
- 资助金额:
$ 1万 - 项目类别: